Details for 2011721756
Up to date per 02.04.2026
Actions
Details for 2011721756
Granted/Registered
European Patent
27.03.2013 A
10.07.2019 B1
20.05.2010
GB
201008401
C08B 37/00 20060101AFI20111205BHEP
Owner
GlaxoSmithKline Biologicals S.A.Rue de l'Institut, 89 1330 RixensartBE
Representative
Representative
SONN Patentanwälte GmbH & Co KGRiemergasse 141010 WienAT
Inventor
CHARLES, PhilippeGlaxoSmithKline Biologicals S.A. rue de l'Institut 89 B-1330 RixensartBE
GELDHOF, GeoffroyGlaxoSmithKline Biologicals S.A. rue de l'Institut 89 B-1330 RixensartBE
MANCUSO, VincentGlaxoSmithKline Biologicals S.A. rue de l'Institut 89 B-1330 RixensartBE
Information about Fees